Glaxo to Acquire Red-Wine Pill Maker Sirtris

This just in: GlaxoSmithKline says it will acquire Sirtris Pharmaceuticals, a Massachusetts biotech company that’s developing a drug based on resveratrol, a chemical found in red wine that is thought to fight some effects of aging. Glaxo said in a news release that the $720 million deal will help it get involved with sirtuins, a [...]